The Effect of Acupressure on the Anxiety Level (Acupres)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04849793 |
|
Recruitment Status :
Completed
First Posted : April 19, 2021
Last Update Posted : January 31, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Anxiety | Other: Acupressure | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 52 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Prospective, parallel, two-arm randomized controlled clinical trial |
| Masking: | Single (Participant) |
| Masking Description: | First of all, the names of all students will be listed alphabetically for the selection of 196 nursing students in the research population and 52 nursing students who will be the sample. Numbers between 1-196 will be written in front of each student in the ordered student list. 52 nursing students will be determined by randomization created in computer environment by an independent researcher who is not included in the study. A total of 52 students in the sample group determined by randomization will be separated according to the A and B groups created by the same statistician in computer environment. |
| Primary Purpose: | Supportive Care |
| Official Title: | The Effect of Acupressure on the Anxiety Level of Senior Nursing Students in the COVID-19 Pandemic |
| Actual Study Start Date : | April 15, 2021 |
| Actual Primary Completion Date : | May 15, 2021 |
| Actual Study Completion Date : | May 15, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Experimental
Before the intervention, the students will be asked to rub the area around the area to be pressed for 20-30 seconds with their palms. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in the area of warming, relaxing and preparatory will be reduced and the tissue will be relieved. After rubbing, each individual's pain threshold level will be taken as a basis in order not to cause tissue damage. The students will be asked to press the designated point manually with their thumb, index or middle finger for 5 seconds with a depth of 1-1.5 cm, rest for 2 seconds and continue the practice for 2 minutes. In the study group, an average of 13 minutes will be applied to HT7, LI4 and EX-HN3 points (five points in total) for two minutes each. The nursing students participating in the research will be given a total of 12 acupressure intervention remotely, three days a week, for four weeks, at least two hours after dinner and when they are calmest.
|
Other: Acupressure
Before starting the application, the students will be asked to rub the area around the area to be pressed for 20-30 seconds with their palms. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in the area of warming, relaxing and preparatory will be reduced and the tissue will be relieved. . The students will be asked to press the designated point manually with their thumb, index or middle finger for 5 seconds with a depth of 1-1.5 cm, rest for 2 seconds and continue the practice for 2 minutes
Other Name: Acupress |
|
No Intervention: Control
No intervention will be made to the control group, only the data will be collected at the same time as the study group.
|
- Anxiety evaluated using the State Anxiety Scale [ Time Frame: Change from before implementation and 4th week of practice ]Scores ranging from 20 to 80 points are obtained in the scale. In the total score obtained from the scale in scoring the scale, 0-19 points indicate the absence of anxiety, 20-39 points indicate mild anxiety, 40-59 points indicate moderate anxiety, and 60-79 points indicate severe anxiety level. Higher state anxiety scores indicate that anxiety level is also high
- Anxiety evaluated using the Trait Anxiety Scale [ Time Frame: Change from before implementation and 4th week of practice ]In the total score obtained from the scale in scoring the scale, 0-19 points indicate the absence of anxiety, 20-39 points indicate mild anxiety, 40-59 points indicate moderate anxiety, and 60-79 points indicate severe anxiety level. Higher trait anxiety scores indicate that anxiety level is also high.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 30 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
The experimental group criteria to be included in the study;
- To voluntarily agree to participate in the study (those who signed the Informed Volunteer Form),
- Not having physical problems that would prevent acupressure application to HT7 (wrist), LI4 (the point where the thumb and index finger meet) and EX-HN3 (the middle point of the right and left eye level),
- Not having experience with acupressure,
- Not using drugs that affect anxiety level (antidepressants, analgesics, beta adrenoreceptor antagonists, dopamine agonists, etc.),
- Not using alcohol and drugs,
- Not having access to the devices required for internet and online education,
- Not being diagnosed with COVID-19 during the study,
- Not having any psychiatric diagnosis.,
The control group criteria to be included in the study;
- To voluntarily agree to participate in the study (those who signed the Informed Volunteer Form),
- Not having experience with acupressure,
- Not using drugs that affect anxiety level (antidepressants, analgesics, beta adrenoreceptor antagonists, dopamine agonists, etc.),
- Not having access to the devices required for internet and online education,
- Not using alcohol and drugs,
- Not being diagnosed with COVID-19 during the study,
- Not having any psychiatric diagnosis
Exclusion Criteria:
The experimental group criteria not to be included in the study;
- Not accepting voluntarily to participate in the study (those who did not sign the Informed Volunteer Form),
- Having a physical problem that prevents acupressure application to HT7 (wrist), LI4 (the point where the thumb and index finger meet) and EX-HN3 (the middle point of the right and left eye level),
- To have an acupressure experience,
- Using drugs that affect anxiety level (antidepressants, analgesics, beta adrenoreceptor antagonists, dopamine agonists, etc.),
- Having access to the devices required for internet and online education,
- Using alcohol and substance,
- Being diagnosed with COVID-19 during the study,
- Any psychiatric diagnosis
The control group criteria not to be included in the study;
- Not accepting voluntarily to participate in the study (those who did not sign the Informed Volunteer Form),
- To have an acupressure experience,
- Using drugs that affect anxiety level (antidepressants, analgesics, beta adrenoreceptor antagonists, dopamine agonists, etc.),
- Having access to the devices required for internet and online education,
- Using alcohol and substance,
- Being diagnosed with COVID-19 during the study,
- Having any psychiatric diagnosis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04849793
| Turkey | |
| Turkey, Mersin University, | |
| Mersin, Turkey | |
| Study Director: | Gülay ALTUN UĞRAŞ, Doctorate | gulaltun@mersin.edu.tr | |
| Principal Investigator: | Seher GÜRDİL YILMAZ, Doctorate | shrgrdl@hotmail.com | |
| Principal Investigator: | Ahmet KARAMAN, Doctorate | ahmet.karaman@mersin.edu.tr | |
| Principal Investigator: | Canan KANAT, MASTER | canankanat@mersin.edu.tr |
| Responsible Party: | Tugba CAM YANIK, Research Assistant, Mersin University |
| ClinicalTrials.gov Identifier: | NCT04849793 |
| Other Study ID Numbers: |
MersinUniversity |
| First Posted: | April 19, 2021 Key Record Dates |
| Last Update Posted: | January 31, 2022 |
| Last Verified: | January 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Acupressure Nursing students Anxiety COVID-19 |
|
Anxiety Disorders Mental Disorders |

